Trademarks and Copyright© The images and information contained in the Site are, to the fullest extent possible, copyrighted and otherwise proprietary. It is the policy of Taro to enforce its intellectual property rights to the fullest extent of the law, including (where applicable) seeking criminal sanctions.

Site Search

Investor Relations

Corporate Profile Welcome to Taro’s Investor Relations Website Established in 1950, Taro Pharmaceutical Industries Ltd. is a research-based, international, specialty pharmaceutical company that develops, manufactures and markets prescription and over-the-counter pharmaceutical products. Taro’s research programs and niche strategy have enabled the Company to achieve gross margins that are among the highest in the specialty pharmaceutical sector. Growth Through Research T... More >>

TAROF (Common Stock) Exchange OTHER OTC (US Dollar) Price $8.20 Change (%)   0.10 (1.23%) Volume 2,270 Data as of 01/05/09 3:48 p.m. ET Click Here for Stock Quote Data on Pink Sheets

Recent News

More >>

Date Title   12/18/08 Taro Files Form 6-K Supplementing Its Preliminary Third Quarter and Year-to-Date 2008 Financial Results 11/11/08 Taro Provides Preliminary Third Quarter and Year-to-Date 2008 Financial Results 09/10/08 Taro Sends Letter to Update Shareholders on Status of Litigation with Sun 07/31/08 Taro and NextWave Announce Agreement to Co-Promote OVIDE(R) in the United States

Primary IR Contact

Roanne Kulakoff Partner Kekst and Company Inc. 437 Madison Avenue 19th Floor New York, NY 10022 Phone: (212) 521-4837 E-mail: Roanne-kulakoff@kekst.com

Taro Pharmaceutical Industries Ltd. c/o Taro Pharmaceuticals U.S.A., Inc. 3 Skyline Drive Hawthorne, NY 10532

Copyright © 2008 MarketWatch, Inc. All rights reserved. Please see our Terms of Use. Designed and powered by Dow Jones Client Solutions Intraday data provided by Interactive Data Real Time Services and subject to the Terms of Use. Intraday data is at least 20-minutes delayed. All times are ET. Historical and current end-of-day data provided by Interactive Data Pricing and Reference Data.